NDC 59368-385 - Micardis HCT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-385
- Package NDCs from labels
- 59368-385-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Micardis HCT - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 45316037-52ec-438f-8780-b2e983fef3f5 | 2026-03-31 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b3228678-7992-4148-b4ab-aa0d8b1b8570 | 2026-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | c2db7e27-952f-c3f6-e053-2995a90af7c1 | 2026-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 59801c48-2af7-4967-ae70-99f865551a7a | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | c2d993ff-b11b-7a62-e053-2995a90a0b00 | 2026-03-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 1d6712a3-bfb3-4081-b8f6-6057eb4baa27 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53ce6e4f-db3a-4789-8bef-1e459fa78b79 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 905568ae-ce27-4978-90c7-b5c93279ecd1 | 2026-03-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 0c8c973f-13a2-4883-8316-4006398e2931 | 2026-03-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Benicar HCT | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | a90915ca-f9d3-4fff-8370-d5dc4cdfc521 | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | St Marys Medical Park Pharmacy | e7b68ea6-4fc8-441a-9640-1ccd3a482d8e | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 2ec371a5-18ba-4ce2-9725-7f99bb73454a | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 1d6ea4b4-1e3c-4f3f-989c-1a3a3c0da6bd | 2026-03-05 | Warnings | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 6d729ec5-7311-4534-9999-9d6fa4f3ba2f | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d838e918-2463-79f6-e053-2a95a90a948d | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 9271a2d7-be94-4e38-9f71-41e8d55e10bc | 2026-03-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lotensin HCT | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Validus Pharmaceuticals LLC | 94c4536f-e28e-48b1-8336-b3939917e99d | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| benazepril hydrochloride and hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | 3f6e6da8-6da3-47c5-a151-e6fd7206890e | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | bdd4348d-928d-ef0b-e053-2a95a90aadb4 | 2026-02-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 7d4ee5ec-5b68-453b-8d6e-214457a58159 | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.